USPTO serial 79100249
CLINTEC
Reviewed by CopyMark Law Group
Reg. 4162941Status 706Registered
- Filing date
- Status date
- Registration date
- Jun 26, 2012
- Examiner
- CARROLL, DORITT
- Law office
- GENERIC WEB UPDATE
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with CLINTEC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Arlene D. Hanks
Arlene D. Hanks Moore & Van Allen PLLC100 North Tryon StreetSuite 4700Charlotte, NC 28202-4003Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business consultation in the field of clinical research [ and pharmaceutical commercialisation; ] compilation and systemization of information into computer databases; database management for others of a database comprised of data collected for clinical and biostatistics research purposes; personnel recruitment and placement in the field of clinical research; compilation and provision of statistical analysis reports; [ statistical consulting services for pharmaceutical, biotechnology and medical device industries for business purposes; ] creation and implementation of statistical analysis plans for business purposes; writing of business reports; business strategic planning [ ; market research, assessment, analysis and evaluation; business feasibility studies ] | ACTIVE | — |
| 041 | [ Educational and ] training services in the field of clinical trials regulation and clinical research; [ Providing, arranging and conducting workshops, seminars, and educational conferences in the field of clinical trials regulation and clinical research; ] training in data capture and management; training [ and education ] in regulatory affairs; [ Providing, arranging and conducting training and educational classes, workshops, seminars, and education conferences in medical writing; providing, arranging and conducting training and educational classes, workshops, seminars, and education conferences training and education in quality control, auditing and inspection; writing of texts; ] training services, namely, training of clinical and scientific researchers to conduct clinical research and drug development studies | ACTIVE | — |
| 042 | Scientific and technological services and research and design in the field of clinical trials and clinical research; industrial analysis and research services in the field of clinical trials and clinical research; clinical research services, namely, implementation of clinical studies and providing reports thereon; [ management of scientific research projects; conducting clinical research projects in the field of clinical trials and clinical research; ] conducting and monitoring clinical trials [ ; quality audit services, quality assurance consultancy, quality control testing in the field of quality control for others; technical inspection services, namely, inspection of clinical data, clinical procedure, clinical process, clinical database, and clinical reports for others; pharmaceutical product evaluation; design and conducting of technical feasibility studies; drug development services; quality management of drug development; preparation of reports in relation to clinical trials and clinical research, including preparation of reports on management of scientific research projects, clinical research projects, clinical trials, audits, pharmaceutical product evaluations, drug development and pharmaceutical product evaluations ] | ACTIVE | — |
| 045 | [ Advisory and consultancy services relating to regulatory affairs in the field of clinical trials, clinical research and drug development; ] advisory and consultancy services relating to national and international regulation of clinical trials and drug development | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Clintec International Limited
- Other trademarks owned by Clintec International Limited
- Other trademarks owned by Clintec International Limited
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named CLINTEC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 17, 2024 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 3, 2024 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Feb 2, 2024 | INPC | INVALIDATION PROCESSED | — |
| Jan 24, 2024 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 24, 2023 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| May 24, 2023 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| May 22, 2023 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Dec 22, 2022 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Dec 22, 2022 | XXXX | POST REGISTRATION ACTION CORRECTION | — |
| Dec 22, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 29, 2022 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Jun 26, 2021 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Mar 25, 2021 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jan 22, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 15, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 15, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 2, 2017 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Dec 2, 2017 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Dec 1, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 3, 2017 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Jun 26, 2017 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Sep 28, 2014 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 28, 2014 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 6, 2013 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 6, 2013 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 2, 2012 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 15, 2012 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 26, 2012 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 26, 2012 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 26, 2012 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 26, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 17, 2012 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| May 11, 2012 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Apr 10, 2012 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 10, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 4, 2012 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 4, 2012 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 21, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 5, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 29, 2012 | ALIE | ASSIGNED TO LIE | — |
| Feb 11, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 10, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 10, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 10, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 18, 2011 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 18, 2011 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 27, 2011 | RFNP | REFUSAL PROCESSED BY IB | — |
| Aug 11, 2011 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 10, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 10, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 10, 2011 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 9, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 8, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 7, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 4, 2011 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |